Building Africa's Biotechnology Platform

From Market Access to Biomanufacturing to Advanced Therapeutics

Genesis Biotechnologies, Inc. is building an integrated biotechnology platform designed to connect scientific expertise, commercial market access, local manufacturing, and advanced therapeutics.

Market Access → Biomanufacturing → Advanced Therapeutics

We believe Africa has the scientific talent, growing demand, and unmet medical needs necessary to build a globally competitive biotechnology sector. The opportunity is to connect that potential with the manufacturing capacity, commercialization infrastructure, and capital required to translate science into products and therapies.

Our Commercial Foundation

For more than 18 years, we have served laboratories and researchers in Ghana and across Africa through laboratory products and biotechnology supplies. Our commercial operations, Genesis-branded products, customer relationships, and expanding distribution capabilities provide an existing foundation for growth. This market access provides Genesis with direct insight into the needs of African researchers and the challenges created by dependence on imported biotechnology products.We are building on this foundation to move beyond distribution and toward biotechnology manufacturing and advanced therapeutics.

Our Platform

1. Market Access

Genesis provides laboratory products and biotechnology supplies to researchers, universities, laboratories, and other scientific organizations.

Our commercial operations provide:

existing customer relationships;
market knowledge;
distribution capabilities;
product-development insight; and
a foundation for regional expansion.

2. Biomanufacturing

Africa remains heavily dependent on imported medical and biotechnology products. Genesis is developing a pathway toward local production of selected high-value biological and biotechnology products. Our strategy includes developing locally manufactured products and expanding manufacturing partnerships to reduce dependence on imported inputs while creating new opportunities for biotechnology production in Africa.

3. Advanced Therapeutics

Genesis is building toward next-generation genetic medicines.

Our scientific focus includes the development of non-viral prime-editing systems, leveraging expertise in gene therapy, genome editing, and therapeutic biotechnology.

Through strategic partnerships with manufacturing organizations in Ghana, Genesis is building access to capabilities relevant to advanced genetic-medicine development, including AAV and CRISPR-LNP manufacturing.

Our Unique Set of Capabilities

We are an early-stage biotechnology company:with capabilities that include:

Commercial access
Existing experience serving African research markets

Scientific expertise
Experience in gene therapy, genome editing, and translational biotechnology.

Manufacturing partnerships
Pathways toward local production of biological and advanced biotechnology products.

Market intelligence
Direct understanding of the products, technologies, and supply-chain challenges faced by African laboratories.

Regional opportunity
A platform that can expand from Ghana into West Africa, broader African, and global markets.

Our long-term strategy is to use commercial market access to support the development of manufacturing capabilities, and to use those capabilities to advance higher-value biotechnology products and therapeutics.

Our Opportunity

Africa imports a substantial proportion of its medical and biotechnology products, creating a significant opportunity for companies that can develop reliable local production and commercialization capabilities.

At the same time, the global cell and gene therapy industry is expanding rapidly. Peer-reviewed economic modeling has projected substantial future revenues from new durable cell and gene therapies, demonstrating the scale of the opportunity in advanced therapeutics.

Genesis is positioned at the intersection of these trends in Africa:

Growing biotechnology demand
+
High dependence on imported products
+
Increasing local manufacturing capability
+
Advanced therapeutic innovation

Partner With Us

Genesis Biotechnologies is building a biotechnology company designed to connect scientific innovation with commercial execution and local manufacturing capacity.

We welcome conversations with:

Strategic Partners

With expertise in manufacturing, biotechnology, therapeutics, and commercialization.

Investors
Interested in biotechnology, healthcare, advanced therapeutics, and emerging markets.

Scientific Collaborators
Working in gene therapy, genome editing, biomanufacturing, and related fields.

Institutions
Seeking to expand biotechnology research, education, and manufacturing capabilities in Africa.